Filtros de búsqueda

Lista de obras de

89Zr-Bevacizumab PET Visualizes Disease Manifestations in Patients with von Hippel-Lindau Disease.

artículo científico publicado en 2016

A review on CXCR4/CXCL12 axis in oncology: no place to hide.

artículo científico

CXCR4 and CXCL12 Expression in Rectal Tumors of Stage IV Patients Before and After Local Radiotherapy and Systemic Neoadjuvant Treatment

artículo científico publicado en 2015

CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy

artículo científico publicado en 2012

Difference in CXCR4 expression between sporadic and VHL-related hemangioblastoma

scientific article published on 26 February 2016

Dopamine and serotonin regulate tumor behavior by affecting angiogenesis

artículo científico

Everolimus Reduces (89)Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors

artículo científico publicado en 2014

False-positive findings on 6-[18F]fluor-l-3,4-dihydroxyphenylalanine PET (18F-FDOPA-PET) performed for imaging of neuroendocrine tumors

artículo científico publicado en 2018

High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer

scientific article published on 18 March 2020

Myocardial metastases on 6-[18F] fluoro-L-DOPA PET/CT: a retrospective analysis of 116 serotonin producing neuroendocrine tumour patients.

artículo científico publicado en 2014

Novel insights into vascularization patterns and angiogenic factors in glioblastoma subclasses

scientific article published on 15 September 2016

PET with the 89Zr-labeled transforming growth factor-β antibody fresolimumab in tumor models

artículo científico publicado en 2011

Pancreatic cyst development: insights from von Hippel-Lindau disease.

artículo científico publicado en 2013

Placental growth factor (PlGF)-specific uptake in tumor microenvironment of 89Zr-labeled PlGF antibody RO5323441.

artículo científico publicado en 2013

Predictors of adherence to exercise interventions during and after cancer treatment: a systematic review.

artículo científico publicado en 2017

Pregnancy-related hemangioblastoma progression and complications in von Hippel-Lindau disease.

artículo científico publicado en 2012

Recruitment of bone marrow derived cells during anti-angiogenic therapy in GBM: the potential of combination strategies

artículo científico publicado en 2014

Response to Alwardat comments on our systematic review entitled: "Predictors of adherence to exercise interventions during and after cancer treatment: A systematic review"

artículo científico publicado en 2018

Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study

artículo científico publicado en 2018

Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.

artículo científico publicado en 2014

Subclassification of newly diagnosed glioblastomas through an immunohistochemical approach.

artículo científico publicado en 2014

TGF-β Antibody Uptake in Recurrent High-Grade Glioma Imaged with 89Zr-Fresolimumab PET.

artículo científico publicado en 2015

Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour.

artículo científico publicado en 2011

Transforming growth factor (TGF)-β expression and activation mechanisms as potential targets for anti-tumor therapy and tumor imaging.

artículo científico

Use of selective serotonin reuptake inhibitors is associated with very low plasma-free serotonin concentrations in humans

artículo científico publicado en 2019

Value of 11C-methionine PET in imaging brain tumours and metastases

artículo científico publicado en 2012

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda